AsiaIPEX is a one-stop-shop for players in the IP industry, facilitating IP trade and connection to the IP world. Whether you are a patent owner interested in selling your IP, or a manufacturer looking to buy technologies to upgrade your operation, you will find the portal a useful resource.

Back to search results

A-32 Cell Therapy for Neurogenic Bladder

Technology Benefits

ΓùÅ Excellent therapeutic effect for sever neurogenic bladderΓùÅ Minimal invasionΓùÅ Long-lasting therapy

Technology Application

Therapy for neurogenic bladder

Detailed Technology Description

None

Supplementary Information

Inventor: YAMAMOTO Tokunori | KOIDE Naoshi | TAKEI Yoshifumi | MATSUKAWA Yoshihisa | FUNAHASHI Yasuhito | GOTOH Momokazu
Priority Number: WO2011043147A1
IPC Current: A61K003512 | A61P001302 | A61P001510 | A61P004300 | C12N00050775
Assignee Applicant: National University Corporation Nagoya University
Title: CELL PREPARATION FOR ERECTILE DYSFUNCTION OR URINARY INCONTINENCE CONTAINING ADIPOSE TISSUE DERIVED MESENCHYMAL STEM CELLS | PRÉPARATION CELLULAIRE CONTRE LE DYSFONCTIONNEMENT ÉRECTILE OU L'INCONTINENCE URINAIRE, CONTENANT DES CELLULES SOUCHES MÉSENCHYMAT
Usefulness: CELL PREPARATION FOR ERECTILE DYSFUNCTION OR URINARY INCONTINENCE CONTAINING ADIPOSE TISSUE DERIVED MESENCHYMAL STEM CELLS | PRÉPARATION CELLULAIRE CONTRE LE DYSFONCTIONNEMENT ÉRECTILE OU L'INCONTINENCE URINAIRE, CONTENANT DES CELLULES SOUCHES MÉSENCHYMATEUSES ISSUES DU TISSU ADIPEUX
Summary: The cell formulation is useful for treating erectile dysfunction and urinary incontinence (claimed).
Novelty: Cell formulation useful for treating erectile dysfunction and urinary incontinence, comprises fat-tissue derived mesenchymal stem cell

Industry

Biomedical

Sub Group

Medical Composition

Country/Region

USA

For more information, please click Here